Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching

Journal of Clinical Microbiology

Volumn 47, Issue 11, 2009, Pages 3520-3523

  Kerremans, J J ^a   Van Der Bij, A K ^a   Goessens, W ^a   Verbrugh, H A ^a   Vos, M C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM DETECTION; BIOLOGICAL MONITORING; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TURNAROUND TIME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SPECIMEN HANDLING; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449627472     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01092-09     Document Type: Article

References (10)

1. Barenfanger, J., C. Drake, and G. Kacich. 1999. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37:1415-1418.
2. Bengtsson, J., M. Wahl, and P. Larsson. 1998. Assessment of the BacT/Alert blood culture system: rapid bacteremia diagnosis with loading throughout the 24 h. Clin. Microbiol. Infect. 4:33-37.
3. Berild, D., A. Mohseni, L. M. Diep, M. Jensenius, and S. H. Ringertz. 2006. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J. Antimicrob. Chemother. 57:326-330.
4. Byl, B., P. Clevenbergh, F. Jacobs, M. J. Struelens, F. Zech, A. Kentos, and J. P. Thys. 1999. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin. Infect. Dis. 29:60-68.
5. Deresinski, S. 2007. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data. Clin. Infect. Dis. 45(Suppl. 3):S177-S183.
6. Doern, G. V., R. Vautour, M. Gaudet, and B. Levy. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32:1757-1762.
7. Munson, E. L., D. J. Diekema, S. E. Beekmann, K. C. Chapin, and G. V. Doern. 2003. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J. Clin. Microbiol. 41:495-497.
8. Riest, G., H. J. Linde, and P. M. Shah. 1997. Comparison of BacT/Alert and BACTEC NR 860 blood culture systems in a laboratory not continuously staffed. Clin. Microbiol. Infect. 3:345-351.
9. Sautter, R. L., A. R. Bills, D. L. Lang, G. Ruschell, B. J. Heiter, and P. P. Bourbeau. 2006. Effects of delayed-entry conditions on the recovery and detection of microorganisms from BacT/ALERT and BACTEC blood culture bottles. J. Clin. Microbiol. 44:1245-1249.
10. Vallés, J., J. Rello, A. Ochagavia, J. Garnacho, and M. A. Alcala. 2003. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123:1615-1624. (Pubitemid 36549784)